GSKNEUTRAL

GSK P/E Ratio Analysis

21.5x

Updated 299h ago·SEC filings & market data

Key Takeaway

The P/E ratio of 21.5x means investors pay $21.50 for every $1 of the company's annual earnings, a common measure of how expensive a stock is relative to its profitability.

Sector Performance

45th percentile

GSK

21.5x

Sector Median

23.1x

Sector Avg

33.8x

Prior Period

17.7x(Jun 2026)

↓ Declining
📊

Deep Analysis

The P/E ratio of 21.5x means investors pay $21.50 for every $1 of the company's annual earnings, a common measure of how expensive a stock is relative to its profitability.

Compared to sector peers, this sits below the exact median of 23.3x, placing GSK in the 45th percentile, so it is slightly cheaper than half of its peer group. The trend data is N/A, with year-over-year change N/A and quarter-over-quarter change N/A, so no directional signal is available from this metric. The level alone offers a mild valuation advantage over the peer median, but without trend information, there is no evidence of improving or deteriorating valuation pressure. This modestly below-median multiple does not create a clear risk or opportunity; it is consistent with a stock that is neither overpriced nor a bargain relative to its sector. Therefore, the metric supports the overall NEUTRAL verdict, as the P/E ratio indicates fair valuation without a compelling edge.

Frequently Asked Questions

What does the P/E Ratio tell investors about GSK?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are GSK's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: CMCSA (7.8x), EG (7.8x), CHRD (7.7x), OXY (7.4x), THC (7.3x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master GSK's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full GSK research report

Free account — no credit card

GSK

21.5x

Sector Median

23.1x

Sector Avg

33.8x

How GSK's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.